Cellular Dynamics International

From WikiMD's Wellness Encyclopedia


Cellular Dynamics International (CDI) is a biotechnology company that specializes in the production of fully functioning human cells in industrial quantities. These cells are used for drug discovery, toxicity testing, and regenerative medicine. CDI was founded in 2004 by James Thomson, a pioneer in the field of stem cell research.

History[edit | edit source]

CDI was established in Madison, Wisconsin and has since become a leader in the field of induced pluripotent stem cells (iPSCs). The company was founded with the goal of harnessing the potential of iPSCs to create a wide variety of human cell types for use in research and therapy. In 2015, CDI was acquired by Fujifilm Holdings Corporation, a Japanese multinational conglomerate.

Technology[edit | edit source]

CDI's core technology revolves around the use of iPSCs, which are adult cells that have been genetically reprogrammed to an embryonic stem cell-like state. This allows them to differentiate into any cell type in the human body. CDI has developed proprietary methods to produce large quantities of high-quality iPSCs and differentiate them into specific cell types, such as cardiomyocytes, neurons, hepatocytes, and endothelial cells.

Applications[edit | edit source]

CDI's products are used in various applications, including:

  • Drug Discovery: Pharmaceutical companies use CDI's human cells to screen potential drug candidates for efficacy and safety.
  • Toxicity Testing: Human cells from CDI are used to test the toxicity of new compounds, reducing the reliance on animal testing.
  • Regenerative Medicine: CDI's cells have potential applications in regenerative medicine, where damaged tissues and organs can be repaired or replaced using lab-grown cells.

Products[edit | edit source]

CDI offers a range of products, including:

  • iCell® Products: These are differentiated human cells derived from iPSCs, available in various cell types.
  • MyCell® Products: Custom iPSC-derived cells tailored to specific research needs, including patient-specific cells for disease modeling.

Research and Development[edit | edit source]

CDI is actively involved in research and development to expand the capabilities and applications of iPSC technology. The company collaborates with academic institutions, pharmaceutical companies, and other biotechnology firms to advance the field of regenerative medicine and drug discovery.

See Also[edit | edit source]

References[edit | edit source]

External Links[edit | edit source]


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD